SHL Telemedicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Cash & Equivalents	6.69	4.48	14.85	4.14
Short-Term Investments	19.56	14.22	17.22	6.48
Cash & Cash Equivalents	26.25	18.7	32.06	10.62
Cash Growth	40.37%	-41.68%	201.82%	-
Receivables	10.35	9.71	9.6	5.94
Inventory	5.37	5.61	4.2	1.37
Other Current Assets	-1.91	-1.73	0	0
Total Current Assets	40.06	32.29	45.86	17.94
Property, Plant & Equipment	12.11	15.69	17.04	15.21
Long-Term Investments	0.33	0.42	0.45	0.44
Goodwill and Intangibles	53.22	54.17	58.3	22.84
Other Long-Term Assets	7.34	8.21	7.95	8.39
Total Long-Term Assets	72.99	78.5	83.73	46.88
Total Assets	113.05	110.78	129.59	64.81
Accounts Payable	12.42	13	11.81	7.99
Deferred Revenue	0.3	0.26	0.56	1.37
Current Debt	4.6	4.43	4.14	3.95
Other Current Liabilities	0.12	0.14	0.86	1.19
Total Current Liabilities	17.44	17.83	17.36	14.5
Long-Term Debt	15.26	22.31	28.36	10.62
Other Long-Term Liabilities	3.89	11.36	23.1	1.82
Total Long-Term Liabilities	19.15	33.67	51.47	12.44
Total Liabilities	36.59	51.49	68.83	26.94
Total Debt	19.86	26.74	32.5	14.57
Debt Growth	-25.74%	-17.72%	123.10%	-
Retained Earnings	-80.13	-73.07	-73	-58.89
Comprehensive Income	-2.72	-1.29	4.41	2.27
Shareholders' Equity	73.53	55.69	56.85	37.88
Net Cash / Debt	6.39	-8.04	-0.44	-3.95
Working Capital	22.62	14.46	28.5	3.44
Book Value Per Share	4.49	3.84	3.92	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).